As per MRFR analysis, the South Korea Personalized Medicine Market Size was estimated at 13.91 (USD Billion) in 2023.The South Korea Personalized Medicine Market is expected to grow from 15.5(USD Billion) in 2024 to 37.7 (USD Billion) by 2035. The South Korea Personalized Medicine Market CAGR (growth rate) is expected to be around 8.416% during the forecast period (2025-2035).
Key South Korea Personalized Medicine Market Trends Highlighted
Numerous important market factors, such as developments in genetics and biotechnology, are causing notable changes in the South Korean personalized medicine market. Research and development is encouraged by the government's efforts to improve healthcare facilities, such as those carried out by the Ministry of Health and Welfare.
As healthcare providers transition from conventional treatments to targeted medicines, increased investments in the biopharmaceutical industry have also contributed to the expansion of personalized medicine.
Partnerships between biotech firms and academic institutions are opening the door to novel, individualized treatment solutions catered to the requirements of each patient. Opportunities-wise, the emergence of big data analytics and artificial intelligence (AI) opens up new growth paths for the South Korean market.
Because of the nation's strong IT infrastructure, combining AI with customized medicine can improve patient outcomes and drug discovery procedures. Additionally, there will probably be a greater need for individualized treatment programs as the population ages and chronic illnesses become more common.
Additionally, a favorable environment for the growth of personalized medicine solutions is being created by patients' and healthcare professionals' increased knowledge of the advantages of customized therapies.
Integrating genetic testing into standard medical procedures is becoming more and more important, according to recent trends in the South Korean personalized medicine market. This change aids in both tracking the efficacy of treatments and early disease detection.
Furthermore, more South Koreans are looking for individualized medical care as preventive healthcare gains greater attention. This trend is also being aided by the growth of telemedicine and digital health technologies, which are opening up individualized treatments to a wider audience.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
South Korea Personalized Medicine Market Drivers
Increasing Prevalence of Chronic Diseases
The rising prevalence of chronic diseases, including cancer, cardiovascular ailments, and diabetes in South Korea is a significant driver for the South Korea Personalized Medicine Market. According to the Korean National Health Insurance Service, chronic diseases account for approximately 60% of all deaths in the country, with cancer being the leading cause.
The incidence rate of cancer in South Korea has steadily increased, with reports indicating a 20% rise in cancer cases over the past decade. This surge necessitates personalized treatment approaches tailored to individual genetic profiles, thereby boosting demand in the personalized medicine sector.
Additionally, organizations such as the Korean Cancer Association are invested in promoting research and treatment strategies that focus on personalized medicine, further enhancing the market growth potential within this region.
Government Support and Initiatives
The South Korean government has been actively promoting personalized medicine through various initiatives, significantly impacting the South Korea Personalized Medicine Market.
In 2020, the government announced its commitment to foster innovative medical technologies, allocating substantial funds to support research and development in the personalized medicine field. The Ministry of Health and Welfare has also prioritized developing a national biobank to enhance genetic research capabilities.
Such supportive measures underscore government involvement, which is crucial for the growth of personalized medicine in South Korea, essentially creating a favorable environment for organizations like the Korea Health Industry Development Institute to contribute to innovations in this sector.
Advancements in Genomic Technologies
The rapid advancement of genomic technologies, particularly in the fields of genetic sequencing and bioinformatics, is driving the growth of the South Korea Personalized Medicine Market. In the past few years, the cost of whole-genome sequencing has decreased significantly, enabling more widespread access to genetic testing.
For example, the Korean Genome Project was launched to sequence and analyze the genomes of Korean individuals, thus enhancing the understanding of genetic dispositions to various diseases. As a result, more healthcare providers are adopting genomic testing as a prerequisite for personalized treatments, making it an essential driver for market growth in the region.
Growing Awareness and Demand for Tailored Treatments
There is a notable increase in awareness and demand for tailored medical treatments among patients in South Korea, contributing to the development of the South Korea Personalized Medicine Market. Educational campaigns led by healthcare providers and patient advocacy groups emphasize the benefits of personalized medicine, leading to a higher demand for individualized treatment plans.
According to recent surveys conducted by the Korea Institute of Healthcare and Social Affairs, over 75% of surveyed patients expressed a keen interest in understanding how their unique genetic profiles could influence treatment outcomes. This growing patient-centric approach aligns with trends observed in global healthcare, propelling growth in the personalized medicine sector in South Korea.
South Korea Personalized Medicine Market Segment Insights
Personalized Medicine Market Product Outlook Insights
The South Korea Personalized Medicine Market is experiencing significant growth, fueled by advancements in technology, an increase in chronic diseases, and a rising demand for tailored healthcare solutions.
Within the Product Outlook segment, several key categories have emerged, including Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, and Personalized Nutrition and Wellness. Personalized Medicine Diagnostics utilizes genomic sequencing and biomarkers to develop personalized treatment plans.
This approach ensures accuracy in diagnosis and treatment, thus optimizing therapeutic outcomes. Personalized Medicine Therapeutics focuses on the development of therapies that are tailored to individual patient profiles, which not only enhances efficacy but also minimizes adverse effects, making it a pivotal area in the market that sees substantial investment and innovation.
The significance of Personalized Medical Care cannot be understated, as it emphasizes patient-centric approaches, integrating data analytics to efficiently manage treatment methodologies and patient information. This market segment aligns with South Korea's healthcare goals of enhancing patient experience and treatment effectiveness through personalized attention.
Furthermore, Personalized Nutrition and Wellness is gaining traction, especially as the population becomes more health-conscious and seeks customized dietary solutions that cater to individual health conditions and genetic profiles.
This aspect of the market addresses the growing trend of preventive healthcare, wherein nutrition plays a vital role in mitigating the risk of diseases. The South Korea Personalized Medicine Market segmentation showcases an industry that is poised for robust growth due to burgeoning consumer demand for personalized approaches aligned with modern healthcare paradigms.
The government of South Korea is also incentivizing personalized medicine initiatives to enhance the overall healthcare landscape, presenting further opportunities for stakeholders within these segments.
Overall, the diverse array of product categories within the South Korea Personalized Medicine Market illustrates its potential to transform traditional healthcare practices into a more individualized approach, thereby contributing to better health outcomes and efficiency in treatment modalities.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Personalized Medicine Market Application Outlook Insights
The South Korea Personalized Medicine Market, particularly in the Application Outlook segment, is experiencing substantial growth, reflecting a wider global trend towards tailored healthcare solutions. Oncology plays a crucial role within this market, as it addresses the rising incidence of cancer, necessitating distinctly targeted therapies that enhance treatment efficacy and minimize side effects.
In addition to oncology, the Central Nervous System (CNS) applications are gaining traction, addressing disorders like Alzheimer's and Parkinson's disease through personalized approaches that adapt to the individual’s specific genetic makeup.
Immunology is another significant area, with personalized treatments offering innovative solutions for autoimmune diseases and allergies, thereby improving patient outcomes. The respiratory segment also holds prominence, particularly with advancements in treating chronic respiratory conditions such as asthma and COPD, highlighting the integration of genetic insights in managing these diseases.
Furthermore, 'Others' encompasses a variety of emerging applications, emphasizing the breadth of personalized medicine's impact in various healthcare facets.
Overall, the South Korea Personalized Medicine Market segmentation reflects a comprehensive approach to healthcare, driven by advancements in biotechnology, increasing patient demand for customized therapies, and supportive government initiatives promoting personalized health solutions.
Personalized Medicine Market End-User Outlook Insights
The South Korea Personalized Medicine Market encompasses a diverse End-User Outlook, which includes Hospitals, Diagnostic Centers, Research Academic Institutes, and Others, playing a pivotal role in the market landscape.
Hospitals form a critical backbone, as they are increasingly utilizing personalized medicine approaches to enhance patient care and treatment outcomes, driven by the rising prevalence of chronic diseases in the region. Diagnostic Centers are gaining traction as they provide essential testing services that facilitate tailored therapies, thus reflecting the growing demand for precision diagnostics in the healthcare system.
Research Academic Institutes contribute significantly to the innovation and development of personalized medicine, focusing on molecular biology and genetics, which is essential for advancing treatment methodologies.
The Others category, encompassing various healthcare facilities and organizations, is also vital, as it supports the integration of personalized medicine into broader healthcare practices. Collectively, these segments form the backbone of the South Korea Personalized Medicine Market, addressing unique healthcare needs and responding to the shift toward more individualized patient care.
The ongoing advancements in technology and growing investments in healthcare are expected to drive further growth across these segments, highlighting the importance of targeted approaches in transforming healthcare delivery in South Korea.
South Korea Personalized Medicine Market Key Players and Competitive Insights
The South Korea Personalized Medicine Market is a rapidly evolving sector characterized by innovation and a focus on tailored healthcare solutions aimed at individual patient needs. With advancements in genomics, diagnostics, and biotechnology, the market is witnessing an increase in the integration of personalized treatment approaches across various medical disciplines.
The competitive landscape is shaped by a mix of established healthcare giants and emerging companies that capitalize on state-of-the-art technology and research capabilities. The incorporation of precision medicine into clinical practices is positioning stakeholders favorably against traditional treatment methodologies, enabling them to deliver higher efficacy and improved patient outcomes.
As stakeholders across the pharmaceutical and healthcare industries adapt to the growing demand for customization in care, the market is expected to undergo significant transformation and expansion over the coming years.
Roche stands out prominently in the South Korea Personalized Medicine Market, leveraging its extensive research capabilities and robust product portfolio. The company has established a strong presence in the field, particularly in diagnostics and therapeutics that align with personalized healthcare objectives.
Roche’s strengths lie in its deep commitment to research and development, enabling it to lead in the development of innovative solutions tailored to patient-specific needs. The company is recognized for its contributions to oncology and molecular diagnostics, enhancing its position as a front-runner in the rapidly evolving personalized medicine landscape.
By actively engaging in collaborations with local healthcare and research institutions, Roche is fueling the advancement of personalized treatments that align with the evolving expectations of the South Korean healthcare system.
Samsung Medical Center, a prominent healthcare institution in South Korea, plays a critical role in the personalized medicine landscape, emphasizing precision care through advanced diagnostics and treatment options. The center offers a range of services including tailored cancer therapies and genetic testing, underscoring its commitment to personalized healthcare.
Samsung Medical Center's strengths are highlighted by its cutting-edge facilities and research initiatives that push the boundaries of conventional medicine. The institution is known for its collaborations with global partners in pursuing innovations that enhance treatment protocols for chronic diseases.
Additionally, the healthcare provider is engaged in strategic partnerships and acquisitions aimed at expanding its capabilities in the field of personalized medicine, positioning itself as a leader in comprehensive patient care.
With a reputation for excellence in medical services, Samsung Medical Center continues to influence the direction of personalized medicine in South Korea, reflecting the growing importance of patient-centric approaches in modern healthcare.
Key Companies in the South Korea Personalized Medicine Market Include
South Korea Personalized Medicine Market Developments
In recent months, the South Korea Personalized Medicine Market has experienced notable advancements and activities. Samsung Medical Center continues to lead in genomic research and patient-specific customized treatment plans, while Genexine is pushing forward with its innovative cancer therapies focused on personalized approaches.
Major pharmaceutical companies like Roche and Novartis are investing in collaborations aimed at enhancing drug delivery systems that cater to genetic variations among patients, thereby reinforcing their foothold in the market.
In August 2023, Celltrion announced a partnership with AbbVie aimed at co-developing personalized therapy options, highlighting the trend toward strategic alliances to leverage expertise.
Furthermore, the growing demand for precision medicine has been reflected in the market valuation, which has seen significant growth driven by advanced genomic technologies and diagnostic tools offered by companies like Seegene and SK Biopharmaceuticals.
Notably, in May 2022, Hanmi Pharmaceutical successfully launched a new personalized treatment protocol, enhancing its market position and catering to the unique needs of patients in South Korea.
The Korean government's strong focus on biotechnology innovation and research is significantly fueling the growth of the personalized medicine segment, as evidenced by investment incentives and increased support for biopharmaceutical research initiatives.
South Korea Personalized Medicine Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 13.91(USD Billion) |
| MARKET SIZE 2024 | 15.5(USD Billion) |
| MARKET SIZE 2035 | 37.7(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.416% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Roche, Samsung Medical Center, Hanmi Pharmaceutical, Amgen, Novartis, Pfizer, Genexine, Seegene, SillaJen, Medtronic, AbbVie, LG Chem, Celltrion, SK Biopharmaceuticals, Korean Biobank |
| SEGMENTS COVERED | Product Outlook, Application Outlook, End-User Outlook |
| KEY MARKET OPPORTUNITIES | Growing genomic sequencing demand, Rise in chronic disease prevalence, Advancements in data analytics, Increasing government support initiatives, Expansion of telemedicine platforms |
| KEY MARKET DYNAMICS | Technological advancements, Growing demand for precision therapies, Government support and funding, Increasing prevalence of chronic diseases, Rising emphasis on genomic research |
| COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The expected market size of the South Korea Personalized Medicine Market in 2024 is valued at 15.5 USD Billion.
The projected market value for the South Korea Personalized Medicine Market by 2035 is 37.7 USD Billion.
The expected CAGR for the South Korea Personalized Medicine Market from 2025 to 2035 is 8.416%.
The Personalized Medicine Therapeutics segment is expected to dominate the market in terms of revenue in 2024, with an expected valuation of 7.0 USD Billion.
The market size for Personalized Medicine Diagnostics is expected to reach 10.0 USD Billion by 2035.
Major players in the South Korea Personalized Medicine Market include Roche, Samsung Medical Center, Hanmi Pharmaceutical, Amgen, and Novartis.
The expected market size for Personalized Medical Care in 2024 is valued at 3.0 USD Billion.
Emerging trends such as advancements in genomics and increasing demand for tailored therapies present significant growth opportunities in the market.
Technological advancements in diagnostics and therapeutics are expected to significantly enhance the growth of the South Korea Personalized Medicine Market.
The expected valuation for the Personalized Nutrition and Wellness segment by 2035 is 3.7 USD Billion.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
